Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$11.8M Buy
56,831
+607
+1% +$120K 1.64% 9
2018
Q2
$10.4M Sell
56,224
-668
-1% -$118K 1.51% 8
2018
Q1
$9.7M Sell
56,892
-567
-1% -$104K 1.07% 15
2017
Q4
$9.99M Sell
57,459
-120
-0.2% -$21.2K 1.1% 13
2017
Q3
$10.7M Buy
57,579
+501
+0.9% +$88.8K 1.3% 7
2017
Q2
$9.83M Buy
57,078
+752
+1% +$122K 1.26% 8
2017
Q1
$9.24M Buy
56,326
+426
+0.8% +$70.8K 1.28% 11
2016
Q4
$8.17M Buy
55,900
+208
+0.4% +$31.3K 1.24% 13
2016
Q3
$9.29M Sell
55,692
-690
-1% -$117K 1.48% 6
2016
Q2
$8.58M Sell
56,382
-270
-0.5% -$42K 1.42% 6
2016
Q1
$8.49M Sell
56,652
-1,870
-3% -$278K 1.39% 6
2015
Q4
$9.5M Sell
58,522
-328
-0.6% -$51.6K 1.47% 7
2015
Q3
$8.14M Buy
58,850
+397
+0.7% +$62.6K 1.24% 17
2015
Q2
$8.97M Buy
58,453
+904
+2% +$145K 1.19% 15
2015
Q1
$9.2M Buy
57,549
+449
+0.8% +$70.7K 1.19% 14
2014
Q4
$9.1M Buy
57,100
+179
+0.3% +$27.9K 1.16% 18
2014
Q3
$8M Buy
56,921
+705
+1% +$92K 1.01% 22
2014
Q2
$6.65M Buy
+56,216
New +$6.51M 0.84% 42

Other funds holding AMGN

AFAM Capital's AMGN Position: Q3 2018 in Review

AFAM Capital increased its Amgen (AMGN) stake by 1.1% in Q3 2018, buying an estimated $120K and bringing the position to 56,831 shares worth $11.8M. The position accounts for 1.64% of the portfolio, ranked #9.

AFAM Capital first reported a position in AMGN in Q2 2014 and has held it in 18 quarters since. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

  • AFAM Capital held 56,831 shares of Amgen worth $11.8M as of Q3 2018.
  • AFAM Capital bought 607 Amgen shares in Q3 2018, an estimated $120K.
  • Amgen made up 1.64% of AFAM Capital's portfolio in Q3 2018, its #9 holding.
  • AFAM Capital first reported a position in Amgen in Q2 2014 and has held it in 18 quarters since.
  • 1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on AFAM Capital's 13F filing for Q3 2018, filed 14 Nov 2018.